Escalon Medical Corp. SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense
Escalon Medical Corp. (ESMC) reported SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense of $118.00 thousand for the 12-month period ending 2023-06-30, per its 10-K filed 2023-10-13.
Discontinued › Notes
us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense · last filed 2023-10-13
- Escalon Medical Corp. sec schedule, 12-09, valuation allowances and reserves, additions, charge to cost and expense for fiscal 2023 was $118.00K, a 24.00% decline from fiscal 2022.
- Escalon Medical Corp. sec schedule, 12-09, valuation allowances and reserves, additions, charge to cost and expense for fiscal 2022 was $155.27K, a 1452.67% increase from fiscal 2021.
- Escalon Medical Corp. sec schedule, 12-09, valuation allowances and reserves, additions, charge to cost and expense for fiscal 2021 was $10.00K, a 16.72% decline from fiscal 2020.
- Escalon Medical Corp. sec schedule, 12-09, valuation allowances and reserves, additions, charge to cost and expense for fiscal 2020 was $12.01K.
| Period end | SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense 12 month |
|---|---|
| 2023-06-30 | $118.00K 10-K · filed 2023-10-13 |
| 2022-06-30 | $155.27K 10-K · filed 2023-10-13 |
| 2021-06-30 | $10.00K 10-K · filed 2022-09-28 |
| 2020-06-30 | $12.01K 10-K · filed 2021-09-27 |